Clarithromycin, by inhibiting the production of intracellular adhesion molecule ICAM-1 and secretion of IL-6 and IL-8, significantly influences the pathophysiological changes associated with infection caused by rhinovirus (RV). This evidence concerns the gene IL6 and infection.